Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Novocure Ltd

NVCR
Current price
16.11 USD -0.56 USD (-3.36%)
Last closed 16.57 USD
ISIN JE00BYSS4X48
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 1 887 025 536 USD
Yield for 12 month +36.18 %
1Y
3Y
5Y
10Y
15Y
NVCR
21.11.2021 - 28.11.2021

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey. Address: No. 4 The Forum, Saint Helier, Jersey, JE2 4UF

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

26.71 USD

P/E ratio

Dividend Yield

Current Year

+509 338 000 USD

Last Year

+537 840 000 USD

Current Quarter

+155 095 000 USD

Last Quarter

+150 356 000 USD

Current Year

+381 058 000 USD

Last Year

+422 973 000 USD

Current Quarter

+119 723 000 USD

Last Quarter

+115 702 000 USD

Key Figures NVCR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -140 611 008 USD
Operating Margin TTM -20.69 %
PE Ratio
Return On Assets TTM -7.93 %
PEG Ratio -0.47
Return On Equity TTM -39.71 %
Wall Street Target Price 26.71 USD
Revenue TTM 577 737 984 USD
Book Value 3.34 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 21.8 %
Dividend Yield
Gross Profit TTM 423 584 000 USD
Earnings per share -1.39 USD
Diluted Eps TTM -1.39 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY -6 %
Profit Margin -25.93 %

Dividend Analytics NVCR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History NVCR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation NVCR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 909.0909
Enterprise Value Revenue 2.7742
Price Sales TTM 3.2662
Enterprise Value EBITDA -6.9219
Price Book MRQ 5.2304

Financials NVCR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NVCR

For 52 weeks

11.29 USD 24.74 USD
50 Day MA 16.58 USD
Shares Short Prior Month 5 488 718
200 Day MA 17 USD
Short Ratio 7.13
Shares Short 5 775 914
Short Percent 6.39 %